Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 10 (4-5) , 209-223
- https://doi.org/10.1016/0166-3542(88)90032-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Peripheral blood mononuclear cell-mediated cytolytic activity during cytomegalovirus (CMV) infection of guinea pigsJournal of Medical Virology, 1988
- Herpes Simplex Virus Glycoprotein Treatment of Recurrent Genital HerpesThe Journal of Infectious Diseases, 1988
- Antibody Response to Herpes Simplex Virus Glycoprotein D: Effects of Acyclovir and Relation to RecurrenceThe Journal of Infectious Diseases, 1987
- Cell‐mediated immunity to varicella‐zoster virus infection in strain 2 guinea pigsJournal of Medical Virology, 1987
- TREATMENT OF FIRST-ATTACK GENITAL HERPES—ACYCLOVIR VERSUS INOSINE PRANOBEXThe Lancet, 1987
- Vaccination with Recombinant Herpes Simplex Virus Glycoproteins: Protection Against Initial and Recurrent Genital HerpesThe Journal of Infectious Diseases, 1987
- Acute Genital Infection in Guinea Pigs: Effect of Recombinant Interleukin-2 on Herpes Simplex Virus Type 2The Journal of Infectious Diseases, 1986
- A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1984
- Suppression of Frequently Recurring Genital HerpesNew England Journal of Medicine, 1984
- Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus.Journal of Clinical Investigation, 1984